Related Experiment Videos
Glucose-6-phosphate dehydrogenase Durham: a de novo mutation associated with chronic hemolytic anemia
S A Zimmerman1, R E Ware, L Forman
1Department of Pediatrics, Duke University Medical Center, Durham, North Carolina 27710, USA.
Insights
Researchers identified a new Glucose-6-phosphate dehydrogenase (G6PD) deficiency variant, G6PD Durham713G, linked to chronic hemolytic anemia. This variant arose from a new mutation, not inherited from the patient's mother.
Area of Science:
- Genetics
- Biochemistry
- Hematology
Background:
- Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a prevalent X-linked genetic disorder.
- It is characterized by red blood cell breakdown, leading to hemolytic anemia.
- Understanding G6PD variants is crucial for diagnosing and managing affected individuals.
Observation:
- A novel G6PD variant, designated G6PD Durham713G, was identified in a patient.
- The patient presented with chronic nonspherocytic hemolytic anemia.
- This variant exhibited a distinct biochemical and enzymatic profile.
Findings:
- The G6PD Durham713G variant is associated with a specific genetic mutation: an A-to-G substitution at nucleotide 713.
- This mutation results in a change from lysine to arginine at amino acid position 238.
- Genetic analysis confirmed this mutation was de novo, originating in the patient and not inherited from the mother.
Implications:
- The discovery of G6PD Durham713G expands the known spectrum of G6PD deficiency-causing mutations.
- This finding aids in understanding the genotype-phenotype correlations in G6PD deficiency.
- Further research into this variant may offer insights into novel therapeutic strategies for hemolytic anemias.
Abstract:
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a common X-linked enzyme defect. We report a new variant, G6PD Durham713G, that is associated with chronic nonspherocytic hemolytic anemia. The G6PD Durham713G variant has a unique biochemical and enzymatic profile and a novel A-->G substitution mutation at nucleotide 713, changing lysine to arginine at amino acid 238. This mutation was not found in the mother of our patient, indicating that G6PD Durham713G resulted from a de novo mutation.